Diabetic Neuropathy, Painful Completed Phase 4 Trials for Cetirizine (DB00341)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03047278Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.Treatment